Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Atea Pharmaceuticals, Inc. (AVIR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/20/2021 |
3
| Adams Jerome M. (Director) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Vavricka John (Chief Commercial Officer) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Duncan Barbara Gayle (Director) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Foster Wayne (See Remarks) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Lucidi Bruno (Director) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Rock Springs Capital Management LP (10% Owner) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| BERGER FRANKLIN M (Director) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Cheng Isaac (Director) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Polsky Bruce (Director) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Sommadossi Jean-Pierre (President, CEO, and Chairman) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Murphy Polly A. (Director) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Hammond Janet MJ (Chief Development Officer) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Corcoran Andrea (See Remarks) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Horga Maria Arantxa (Acting Chief Medical Officer) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Chu Chung K. (10% Owner) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Hack Andrew A. F. (Director) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
10/29/2020 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
|
|